Concepedia

<p>Knockdown of ATAD2 Inhibits Proliferation and Tumorigenicity Through the Rb-E2F1 Pathway and Serves as a Novel Prognostic Indicator in Gastric Cancer</p>

Xuan Zhou, Huihui Ji, Dongxue Ye, Hong Li, Fen Liu, Haiyan Li, Jin Xu, Yujun Li, Fenggang Xiang

Cancer Management and Research · 2020 · 25 citations · 18 references

DOIFull text

Open access

Abstract

Our study indicated that ATAD2 plays an important role in the process of tumorigenesis and progression in GC, and it could serve as a novel prognostic biomarker and a therapeutic target for the treatment of GC patients.

References

18

Analyzing real-time PCR data by the comparative CT method

Thomas D. Schmittgen, Kenneth J. Livak · Nature Protocols · 2008 · 26K citations

, , +8

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Ash A. Alizadeh, Michael B. Eisen, R. Eric Davis et al. · Nature · 2000 · 9.9K citations

, , +8

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Elizabeth Smyth, Marcel Verheij, William Allum et al. · Annals of Oncology · 2016 · 1.6K citations

, , +7

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Alicia Okines, Marcel Verheij, William Allum et al. · Annals of Oncology · 2010 · 1.3K citations

, , +7

ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors

Marco Cirò, Elena Prosperini, Micaela Quarto et al. · Cancer Research · 2009 · 239 citations · Full text

, , +18